Loading market dashboard
EyePoint Pharmaceuticals, Inc.
EYPTHealthcareNASDAQUS
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
EyePoint Pharmaceuticals, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $845.75M | $24.97M - $1.67B | -$845.75M | $2.438 | 4 |
| Dec 2029 | $564.43M | $16.66M - $1.11B | -$564.43M | $0.496 | 4 |
| Dec 2028 | $284.86M | $284.85M - $284.87M | -$284.86M | -$1.367 | 9 |
| Dec 2027 | $47.70M | $918.3K - $94.48M | -$47.70M | -$2.851 | 8 |
| Dec 2026 | $1.73M | $1.21M - $2.77M | -$1.73M | -$3.542 | 9 |
| Dec 2025 | $31.77M | $31.20M - $32.37M | -$31.77M | -$3.033 | 8 |
| Dec 2024 | $42.55M | $37.33M - $53.20M | -$42.55M | -$2.173 | 8 |
| Dec 2023 | $50.39M | $1.49M - $99.45M | -$50.39M | -$1.86 | 7 |
| Dec 2022 | $41.28M | $39.10M - $47.21M | -$56.26M | -$2.185 | 2 |
| Dec 2021 | $35.19M | $33.33M - $40.25M | -$35.19M | -$1.954 | 5 |
| Dec 2020 | $45.60M | $43.19M - $52.16M | -$45.60M | -$1.82 | 3 |
| Dec 2019 | $18.85M | $17.85M - $21.56M | -$18.85M | -$5.675 | 3 |